Lu Chen

Lu Chen

Recursion Pharmaceuticals - - / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4523511
-
person_outline Lu Chen's MOST POPULAR ARTICLES
1-) Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeNT Ihle, LA Byers, ES Kim, P Saintigny, JJ Lee, GR Blumenschein, A Tsao, ...Journal of the National Cancer Institute 104 (3), 228-239, 20124892012
2-) Inhibition of B cell receptor signaling by ibrutinib in primary CNS lymphomaMS Lionakis, K Dunleavy, M Roschewski, BC Widemann, JA Butman, ...Cancer Cell 31 (6), 833-843. e5, 20173852017
3-) A multiprotein supercomplex controlling oncogenic signalling in lymphomaJD Phelan, RM Young, DE Webster, S Roulland, GW Wright, M Kasbekar, ...Nature 560 (7718), 387-391, 20182512018
4-) Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitroQ Zhang, CZ Chen, M Swaroop, M Xu, L Wang, J Lee, AQ Wang, ...Cell discovery 6 (1), 80, 20202372020
5-) Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screeningGL Lin, KM Wilson, M Ceribelli, BZ Stanton, PJ Woo, S Kreimer, EY Qin, ...Science translational medicine 11 (519), eaaw0064, 20191762019